Each gram of cream/ointment contains Clobetasol Propionate BP 0.5 mg.

Temovate® cream/ointment contains the active compound Clobetasol Propionate, a synthetic corticosteroid for topical dermatologic use. Clobetasol, an analog of prednisolone, has a high degree of glucocorticoid activity and a slight degree of mineralocorticoid activity.

Temovate® is a super-high potency corticosteroid formulation indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Apply a thin layer of Temovate® to the affected skin area twice daily and rub in gently and completely.

Temovate® cream/ointment is contraindicated in patients with a history of hypersensitivity to any of the components of the preparation.

General: Long-term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion.

Pregnancy and Lactation: The administration of Temovate® cream/ointment during pregnancy and lactation should be considered only if the expected benefit to the mother outweighs any possible risk to the fetus.

Pediatric Use: Safety and effectiveness of Temovate® in pediatric patients under 12 years have not been established.

Adverse Reactions

In controlled trials with all Clobetasol Propionate formulations, the following adverse reactions have been reported:
Burning/stinging
Pruritus
Irritation
Erythema
Folliculitis
Cracking and fissuring of the skin
Numbness of the fingers
Tenderness in the elbow
Skin atrophy
Telangiectasia

Acute overdosage is very unlikely to occur. However, in the case of chronic overdosage or misuse, the features of hypercortisolism may appear.

It is for external use only.
Avoid contact with the eyes.
The treated skin area should not be bandaged.

Store at a temperature not exceeding 30°C. Protect from light.